Imatinib Mesylate in Treating Patients With Gliomas

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

August 31, 2004

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

imatinib mesylate

Trial Locations (10)

21079

Centre de Lutte Contre le Cancer, Georges-Francois Leclerc, Dijon

35100

Azienda Ospedaliera di Padova, Padua

44805

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

A-1100

Kaiser Franz Josef Hospital, Vienna

B-3000

U.Z. Gasthuisberg, Leuven

06189

Centre Antoine Lacassagne, Nice

F-94805

Institut Gustave Roussy, Villejuif

3008 AE

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

G11 6NT

Beatson Oncology Centre, Glasgow

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00039364 - Imatinib Mesylate in Treating Patients With Gliomas | Biotech Hunter | Biotech Hunter